New cancer therapy by immunomanipulation: Development of immunotherapy for human melanoma as a model system

Yutaka Kawakami

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Purpose and Methods. T cells play an important role in in vivo rejection of human melanoma. Human melanoma antigens recognized by autologous T cells were identified. These antigens are classified as tissue (melanocyte)- specific proteins, cancer-testis antigens (proteins expressed in normal testis and various cancers), tumor-specific peptides derived from mutations in tumor cells, and others. Results. A variety of mechanisms generating T cell epitopes on tumor cells were discovered. Various clinical observations, including tumor regression observed in adoptive transfer of gp 100-reactive T cells suggest that these identified melanoma peptides may function as tumor rejection antigens. Immunodominant common epitopes that could expand melanoma-reactive cytotoxic T lymphocytes (CTLs) in vitro were found in the MART-1 and gp 100 antigens. New immunization protocols - including immunization with peptides, recombinant viruses, plasmid DNAs, and dendritic cells pulsed with peptides as well as adoptive transfer of in vitro-generated CTLs by stimulation with antigenic peptides - were developed (phase I clinical trials have been performed in the Surgery Branch of the National Cancer Institute, Bethesda, MD, U.S.A.). Immunization with the gp100(209(210M)) peptide that was modified to have high HLA-A2 binding affinity, along with incomplete Freund's adjuvant and interleukin (IL)-2, resulted in a 42% response rate in patients with melanoma. Conclusion. These immunotherapies need further improvement due to the mechanisms of tumor escape from T cell responses.

Original languageEnglish
Pages (from-to)S2-S6
JournalCornea
Volume19
Issue number3 SUPPL. 1
DOIs
Publication statusPublished - 2000 May 1

Keywords

  • Dendritic cells
  • Gp 100
  • Immunotherapy
  • Melanoma
  • Tumor antigens

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'New cancer therapy by immunomanipulation: Development of immunotherapy for human melanoma as a model system'. Together they form a unique fingerprint.

Cite this